|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Zongjie (Daniel) WangPublisher: Taylor & Francis Ltd Imprint: CRC Press ISBN: 9781032862392ISBN 10: 1032862394 Pages: 312 Publication Date: 30 January 2026 Audience: College/higher education , Professional and scholarly , Tertiary & Higher Education , Professional & Vocational Format: Hardback Publisher's Status: Forthcoming Availability: Not yet available This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release. Table of ContentsReviewsAuthor InformationDr. Zongjie (Daniel) Wang is a Group Leader at the Chan Zuckerberg Biohub Network and an affiliated member of Northwestern University. His research focuses on the development and application of microfluidic systems for next-generation precision medicine, including high-throughput platforms for cell analysis and their integration into cancer immunotherapy and biomolecular screening. Dr. Wang has co-authored over 50 peer-reviewed articles, which have collectively received more than 5,000 citations. His pioneering work and perspectives have been published in leading journal, and he is the recipient of numerous honors, including the UBC Young Alumni Achievement Award, the ISAC President’s Award for Excellence, the Dimitris N. Chorafas Foundation Prize, and the Extraordinary Potential Award from the China Scholarship Council. Dr. Wang is also a co-founder of CTRL Therapeutics, a startup advancing microfluidic cell-sorting technologies for cancer immunotherapy. Tab Content 6Author Website:Countries AvailableAll regions |
||||